Is EUDA Health Stock a Good Investment?
EUDA Health Investment Advice | EUDAW |
- Examine EUDA Health's financial health by looking at its balance sheet, income statement, and cash flow statement. Analyze key financial ratios, such as Price-to-Earnings (P/E), Price-to-Sales (P/S), and Price-to-Book (P/B), to determine whether the stock is fairly valued or over/undervalued.
- Research EUDA Health's leadership team and their track record. Good management can help EUDA Health navigate difficult times and make strategic decisions that benefit shareholders and increases its net worth.
- Consider the overall health of the Health Care Equipment & Supplies space and any emerging trends that could impact EUDA Health's business and its evolving consumer preferences.
- Compare EUDA Health's performance and market position to its competitors. Analyze how EUDA Health is positioned in terms of product offerings, innovation, and market share.
- Check if EUDA Health pays a dividend and its dividend yield and payout ratio.
- Review what financial analysts are saying about EUDA Health's stock and their price targets. However, remember that analysts' opinions can vary, and their predictions may not always be accurate.
It's important to note that investing in EUDA Health Holdings stock, carries risks, and you should carefully consider your investment goals and risk tolerance before making any investment decisions. Also, remember that it's important for investors to have a long-term perspective and a well-diversified portfolio to manage the impact of stock market volatility on their investments. Below is a detailed guide on how to decide if EUDA Health Holdings is a good investment.
Sell | Buy |
Strong Sell
Market Performance | OK | Details | |
Volatility | Out of control | Details | |
Hype Condition | Stale | Details | |
Current Valuation | Overvalued | Details | |
Odds Of Distress | High | Details | |
Economic Sensitivity | Very regressive towards the market | Details | |
Investor Sentiment | Impartial | Details | |
Analyst Consensus | Not Available | Details | |
Financial Strenth (F Score) | Healthy | Details | |
Financial Leverage | Inapplicable | Details | |
Reporting Quality (M-Score) | Unlikely Manipulator | Details |
Examine EUDA Health Stock
Researching EUDA Health's stock involves analyzing various aspects of the company and its industry to make an informed investment decision. The key areas to focus on are fundamentals, business model and competitive advantage. It is also important to analyze trends in revenue, net income, and cash flow, as well as key financial ratios, such as price-to-earnings (P/E), price-to-sales (P/S), and debt-to-equity (D/E). The company had not issued any dividends in recent years.
To determine if EUDA Health is a good investment, evaluating the company's potential for future growth is also very important. This may include expanding into new markets, launching new products or services, or improving operational efficiency. Companies with strong growth prospects can be more attractive investments. This aspect of the research should be conducted in the context of the overall market and industry in which the company operates and should include an analysis of growth potential, competitive landscape, and any regulatory or economic factors that could impact the business. Some of the essential points regarding EUDA Health's research are outlined below:
EUDA Health Holdings is way too risky over 90 days horizon | |
EUDA Health Holdings has some characteristics of a very speculative penny stock | |
EUDA Health Holdings appears to be risky and price may revert if volatility continues | |
EUDA Health Holdings has high likelihood to experience some financial distress in the next 2 years | |
The company reported the revenue of 3.71 M. Net Loss for the year was (8.44 M) with profit before overhead, payroll, taxes, and interest of 0. | |
EUDA Health generates negative cash flow from operations |
EUDA Health Quarterly Liabilities And Stockholders Equity |
|
EUDA Health's profitablity analysis
Last Reported | Projected for Next Year | ||
Return On Tangible Assets | (7.66) | (7.28) | |
Return On Capital Employed | 0.53 | 0.56 | |
Return On Assets | (7.66) | (7.28) | |
Return On Equity | 1.34 | 1.91 |
Determining EUDA Health's profitability involves analyzing its financial statements and using various financial metrics to determine if EUDA Health is a good buy. For example, gross profit margin measures EUDA Health's profitability after accounting for the cost of goods sold, while net profit margin measures profitability after accounting for all expenses. Other important metrics include return on assets, return on equity, and free cash flow. By reviewing multiple sources and metrics, you can gain a complete picture of EUDA Health's profitability and make more informed investment decisions.
Please note, the imprecision that can be found in EUDA Health's accounting process means that the reasonable investor should take a skeptical approach toward the financial statement analysis of EUDA Health Holdings. Check EUDA Health's Beneish M Score to see the likelihood of EUDA Health's management manipulating its earnings.
Evaluate EUDA Health's management efficiency
The company has return on total asset (ROA) of (0.863) % which means that it has lost $0.863 on every $100 spent on assets. This is way below average. EUDA Health's management efficiency ratios could be used to measure how well EUDA Health manages its routine affairs as well as how well it operates its assets and liabilities. At this time, EUDA Health's Return On Capital Employed is fairly stable compared to the past year. Return On Equity is likely to climb to 1.91 in 2024, despite the fact that Return On Tangible Assets are likely to grow to (7.28). At this time, EUDA Health's Intangible Assets are fairly stable compared to the past year. Non Currrent Assets Other is likely to climb to about 399.1 K in 2024, whereas Non Current Assets Total are likely to drop slightly above 557.7 K in 2024.Last Reported | Projected for Next Year | ||
Book Value Per Share | (0.33) | (0.31) | |
Tangible Book Value Per Share | (0.33) | (0.34) | |
Enterprise Value Over EBITDA | (4.33) | (4.11) | |
Price Book Value Ratio | (4.37) | (4.59) | |
Enterprise Value Multiple | (4.33) | (4.11) | |
Price Fair Value | (4.37) | (4.59) | |
Enterprise Value | 35.9 M | 34.1 M |
Evaluating the management effectiveness of EUDA Health allows investors to assess its financial health and operational efficiency. Coupled with an analysis of its growth prospects and the current market dynamics, we evaluate the stock's true value and future potential. Key indicators such as revenue, earnings or debt levels are examined alongside external factors like economic trends and regulatory changes. The EUDA Stock analysis seeks to determine whether the stock is undervalued, appropriately priced, or overvalued, thereby guiding your investment decisions.
Beta (0) |
Basic technical analysis of EUDA Stock
As of the 28th of November, EUDA Health shows the Coefficient Of Variation of 3537.5, mean deviation of 10.51, and Downside Deviation of 17.94. EUDA Health Holdings technical analysis allows you to utilize historical prices and volume patterns in order to determine a pattern that computes the direction of the firm's future prices. Please confirm EUDA Health Holdings standard deviation, as well as the relationship between the maximum drawdown and expected short fall to decide if EUDA Health Holdings is priced adequately, providing market reflects its regular price of 0.09 per share. As EUDA Health Holdings appears to be a penny stock we also advise to verify its total risk alpha numbers.Understand EUDA Health's technical and predictive indicators
Using predictive indicators to make investment decisions involves analyzing EUDA Health's various financial and market-based factors to help forecast future trends and identify investment opportunities. Select the indicators that are most relevant to your investment strategy. Each indicator has its own strengths and weaknesses, so it's essential to combine multiple indicators to get a more comprehensive view of the market and reduce the risk of making poor decisions based on limited data.
Risk Adjusted Performance | 0.0312 | |||
Market Risk Adjusted Performance | (0.08) | |||
Mean Deviation | 10.51 | |||
Semi Deviation | 12.38 | |||
Downside Deviation | 17.94 | |||
Coefficient Of Variation | 3537.5 | |||
Standard Deviation | 16.82 | |||
Variance | 283.05 | |||
Information Ratio | 0.0208 | |||
Jensen Alpha | 1.08 | |||
Total Risk Alpha | (2.07) | |||
Sortino Ratio | 0.0195 | |||
Treynor Ratio | (0.09) | |||
Maximum Drawdown | 97.2 | |||
Value At Risk | (24.75) | |||
Potential Upside | 33.5 | |||
Downside Variance | 321.92 | |||
Semi Variance | 153.16 | |||
Expected Short fall | (14.30) | |||
Skewness | 1.15 | |||
Kurtosis | 3.94 |
Risk Adjusted Performance | 0.0312 | |||
Market Risk Adjusted Performance | (0.08) | |||
Mean Deviation | 10.51 | |||
Semi Deviation | 12.38 | |||
Downside Deviation | 17.94 | |||
Coefficient Of Variation | 3537.5 | |||
Standard Deviation | 16.82 | |||
Variance | 283.05 | |||
Information Ratio | 0.0208 | |||
Jensen Alpha | 1.08 | |||
Total Risk Alpha | (2.07) | |||
Sortino Ratio | 0.0195 | |||
Treynor Ratio | (0.09) | |||
Maximum Drawdown | 97.2 | |||
Value At Risk | (24.75) | |||
Potential Upside | 33.5 | |||
Downside Variance | 321.92 | |||
Semi Variance | 153.16 | |||
Expected Short fall | (14.30) | |||
Skewness | 1.15 | |||
Kurtosis | 3.94 |
Consider EUDA Health's intraday indicators
EUDA Health intraday indicators are useful technical analysis tools used by many experienced traders. Just like the conventional technical analysis, daily indicators help intraday investors to analyze the price movement with the timing of EUDA Health stock daily movement. By combining multiple daily indicators into a single trading strategy, you can limit your risk while still earning strong returns on your managed positions.
Daily Balance Of Power | (9,223,372,036,855) | |||
Rate Of Daily Change | 0.95 | |||
Day Median Price | 0.09 | |||
Day Typical Price | 0.09 | |||
Price Action Indicator | (0) | |||
Period Momentum Indicator | (0.01) |
EUDA Stock media impact
Far too much social signal, news, headlines, and media speculation about EUDA Health that are available to investors today. That information is available publicly through EUDA media outlets and privately through word of mouth or via EUDA internal channels. However, regardless of the origin, that massive amount of EUDA data is challenging to quantify into actionable patterns, especially for investors that are not very sophisticated with ever-evolving tools and techniques used in the investment management field.
A primary focus of EUDA Health news analysis is to determine if its current price reflects all relevant headlines and social signals impacting the current market conditions. A news analyst typically looks at the history of EUDA Health relative headlines and hype rather than examining external drivers such as technical or fundamental data. It is believed that price action tends to repeat itself due to investors' collective, patterned thinking related to EUDA Health's headlines and news coverage data. This data is often completely overlooked or insufficiently analyzed for actionable insights to drive EUDA Health alpha.
EUDA Health Corporate Management
Wei Chen | CEO Director | Profile | |
Steven Sobak | Chief Officer | Profile | |
Daniel Tan | Chief Officer | Profile | |
Yew CPA | Chief Officer | Profile |
Additional Tools for EUDA Stock Analysis
When running EUDA Health's price analysis, check to measure EUDA Health's market volatility, profitability, liquidity, solvency, efficiency, growth potential, financial leverage, and other vital indicators. We have many different tools that can be utilized to determine how healthy EUDA Health is operating at the current time. Most of EUDA Health's value examination focuses on studying past and present price action to predict the probability of EUDA Health's future price movements. You can analyze the entity against its peers and the financial market as a whole to determine factors that move EUDA Health's price. Additionally, you may evaluate how the addition of EUDA Health to your portfolios can decrease your overall portfolio volatility.